<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="Publisher" Owner="NLM">        <PMID Version="1">30385276</PMID>        <DateRevised>            <Year>2018</Year>            <Month>11</Month>            <Day>02</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">1879-355X</ISSN>                <JournalIssue CitedMedium="Internet">                    <PubDate>                        <Year>2018</Year>                        <Month>Oct</Month>                        <Day>29</Day>                    </PubDate>                </JournalIssue>                <Title>International journal of radiation oncology, biology, physics</Title>                <ISOAbbreviation>Int. J. Radiat. Oncol. Biol. Phys.</ISOAbbreviation>            </Journal>            <ArticleTitle>Radiation Dose-Response For Risk Of Myocardial Infarction In Breast Cancer Survivors.</ArticleTitle>            <ELocationID EIdType="pii" ValidYN="Y">S0360-3016(18)33914-2</ELocationID>            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijrobp.2018.10.025</ELocationID>            <Abstract>                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Previous reports suggest that radiotherapy for breast cancer (BC) can cause ischemic heart disease, with the radiation-related risk increasing linearly with mean whole heart dose (MWHD). This study aimed to validate these findings in younger BC patients and to investigate additional risk factors for radiation-related myocardial infarction (MI).</AbstractText>                <AbstractText Label="METHODS" NlmCategory="METHODS">A nested case-control study was conducted within a cohort of BC survivors treated during 1970-2009. Cases were 183 patients with MI as their first heart disease after BC. One control per case was selected, matched on age and BC diagnosis date. Information on treatment and cardiovascular risk factors was abstracted from medical- and radiation-charts. Cardiac doses were estimated for each woman by reconstructing her regimen using modern 3D computed tomography (CT) planning on a typical patient CT-scan.</AbstractText>                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Median age at BC of cases and controls was 50.2 years (interquartile range (IQR): 45.7-54.7). Median time to MI was 13.6 years (IQR: 9.9-18.1). Median MWHD was 8.9 Gray (Gy) (range: 0.3-35.2 Gy). MI rate increased linearly with increasing MWHD (excess rate ratio (ERR) per Gy: 6.4%, 95% confidence interval (95% CI): 1.3%-16.0%). Patients receiving ≥20 Gy MWHD had a 3.4-fold (95% CI: 1.5-7.6) higher MI rate than unirradiated patients. ERRs were higher for younger women, with borderline significance (ERR<sub>&lt;45years</sub>: 24.2%/Gy, ERR<sub>≥50years</sub>: 2.5%/Gy, p<sub>interaction</sub>=0.054). Whole heart dose-volume parameters did not modify the dose-response relationship significantly.</AbstractText>                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">MI rate after radiation for BC increases linearly with MWHD. Reductions in MWHD are expected to contribute to better cardiovascular health of BC survivors.</AbstractText>                <CopyrightInformation>Copyright © 2018. Published by Elsevier Inc.</CopyrightInformation>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Jacobse</LastName>                    <ForeName>Judy N</ForeName>                    <Initials>JN</Initials>                    <AffiliationInfo>                        <Affiliation>Netherlands Cancer Institute, Department of Psychosocial Research and Epidemiology, Amsterdam, The Netherlands.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Duane</LastName>                    <ForeName>Frances K</ForeName>                    <Initials>FK</Initials>                    <AffiliationInfo>                        <Affiliation>Medical Research Council Population Health Research Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Boekel</LastName>                    <ForeName>Naomi B</ForeName>                    <Initials>NB</Initials>                    <AffiliationInfo>                        <Affiliation>Netherlands Cancer Institute, Department of Psychosocial Research and Epidemiology, Amsterdam, The Netherlands.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Schaapveld</LastName>                    <ForeName>Michael</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>Netherlands Cancer Institute, Department of Psychosocial Research and Epidemiology, Amsterdam, The Netherlands.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Hauptmann</LastName>                    <ForeName>Michael</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>Netherlands Cancer Institute, Department of Biostatistics, Amsterdam, The Netherlands.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Hooning</LastName>                    <ForeName>Maartje J</ForeName>                    <Initials>MJ</Initials>                    <AffiliationInfo>                        <Affiliation>Erasmus MC - Cancer Institute, Medical Oncology, Rotterdam, The Netherlands.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Seynaeve</LastName>                    <ForeName>Caroline M</ForeName>                    <Initials>CM</Initials>                    <AffiliationInfo>                        <Affiliation>Erasmus MC - Cancer Institute, Medical Oncology, Rotterdam, The Netherlands.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Baaijens</LastName>                    <ForeName>Margreet H A</ForeName>                    <Initials>MHA</Initials>                    <AffiliationInfo>                        <Affiliation>Erasmus MC - Cancer Institute, Radiation Oncology, Rotterdam, The Netherlands.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Gietema</LastName>                    <ForeName>Jourik A</ForeName>                    <Initials>JA</Initials>                    <AffiliationInfo>                        <Affiliation>University Medical Center Groningen, Medical Oncology, Groningen, The Netherlands.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Darby</LastName>                    <ForeName>Sarah C</ForeName>                    <Initials>SC</Initials>                    <AffiliationInfo>                        <Affiliation>Clinical Trial Service Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>van Leeuwen</LastName>                    <ForeName>Flora E</ForeName>                    <Initials>FE</Initials>                    <AffiliationInfo>                        <Affiliation>Netherlands Cancer Institute, Department of Psychosocial Research and Epidemiology, Amsterdam, The Netherlands.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Aleman</LastName>                    <ForeName>Berthe M P</ForeName>                    <Initials>BMP</Initials>                    <AffiliationInfo>                        <Affiliation>Netherlands Cancer Institute, Radiation Oncology, Amsterdam, The Netherlands. Electronic address: b.aleman@nki.nl.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Taylor</LastName>                    <ForeName>Carolyn W</ForeName>                    <Initials>CW</Initials>                    <AffiliationInfo>                        <Affiliation>Clinical Trial Service Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>10</Month>                <Day>29</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>United States</Country>            <MedlineTA>Int J Radiat Oncol Biol Phys</MedlineTA>            <NlmUniqueID>7603616</NlmUniqueID>            <ISSNLinking>0360-3016</ISSNLinking>        </MedlineJournalInfo>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>06</Month>                <Day>15</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="revised">                <Year>2018</Year>                <Month>10</Month>                <Day>07</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>10</Month>                <Day>19</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>11</Month>                <Day>3</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>11</Month>                <Day>6</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>11</Month>                <Day>6</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>aheadofprint</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30385276</ArticleId>            <ArticleId IdType="pii">S0360-3016(18)33914-2</ArticleId>            <ArticleId IdType="doi">10.1016/j.ijrobp.2018.10.025</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>